Literature DB >> 84989

Unwanted effects of fluphenazine enanthate and decanoate.

S H Curry, A C Altamura, S Montgomery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84989     DOI: 10.1016/s0140-6736(79)90749-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.

Authors:  A Cario Altamura; Francesca Sassella; Annalisa Santini; Clauno Montresor; Sara Fumagalli; Emanuela Mundo
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.

Authors:  A Jørgensen; J Andersen; N Bjørndal; S J Dencker; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.

Authors:  A C Altamura; S H Curry; S Montgomery; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review.

Authors:  Simon Zhornitsky; Emmanuel Stip
Journal:  Schizophr Res Treatment       Date:  2012-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.